| |
Highlighted member publications
Check out highlighted UF Health Cancer Center member publications from the past month. Contact Research Development with questions.
Cancer Control and Population SciencesYu Z, Peng C, Yang X, Dang C, Adekkanattu P, Gopal Patra B, Peng Y, Pathak J, Wilson DL, Chang CY, Lo-Ciganic WH, George TJ, Hogan WR, Guo Y, Bian J, Wu Y. Identifying social determinants of health from clinical narratives: A study of performance, documentation ratio, and potential bias. J Biomed Inform. 2024 Apr 14;153:104642. doi: 10.1016/j.jbi.2024.104642 Alpert JM, Hampton CN, Campbell-Salome G, Paige S, Murphy M, Heffron E, Amin TB, Harle CA, Le T, Vasquez TS, Xue W, Markham MJ, Bylund CL. Tele-Oncology Use During the COVID-19 Pandemic: Patient Experiences and Communication Behaviors with Clinicians. Telemed J E Health. 2024 Apr 4. doi: 10.1089/tmj.2023.0372 See all Cancer Control and Population Sciences publications.
Cancer Targeting and Therapeutics
Luboff AJ, DeRemer DL. Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer. Ann Pharmacother. 2024 Apr 2:10600280241241531. doi: 10.1177/10600280241241531 von Roemeling C, Ferreri AJM, Soussain C, Tun HW, Grommes C. Targets and treatments in primary CNS lymphoma. Leuk Lymphoma. 2024 Apr 24:1-13. doi: 10.1080/10428194.2024.2342560 See all Cancer Targeting and Therapeutics publications.
Immuno-Oncology and Microbiome
Tian J, Mallinger JC, Shi P, Ling D, Deleyrolle LP, Lin M, Khoshbouei H, Sarkisian MR. Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner. Transl Oncol. 2024 Apr 18;45:101956. doi: 10.1016/j.tranon.2024.101956 Kim MC, De U, Borcherding N, Wang L, Paek J, Bhattacharyya I, Yu Q, Kolb R, Drashansky T, Thatayatikom A, Zhang W, Cha S. Single-cell transcriptomics unveil profiles and interplay of immune subsets in rare autoimmune childhood Sjogren’s disease. Commun Biol. 2024 Apr 19;7(1):481. doi: 10.1038/s42003-024-06124-6
See all Immuno-Oncology and Microbiome publications.
Mechanisms of OncogenesisSobh A, Encinas E, Patel AM, Surapaneni G, Bonilla E, Kaestner CL, Poullard J PA-S, Clerio M, Vasan K, Freeman T, Lv D, Dupere-Richer D, Riva A, Barwick BG, Zhou D, Boise LH, Mitsiades CS, Kim B, Bennett RL, Chandel NS, Licht JD. NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome. Blood. 2024 Apr 10:blood.2023022859. doi: 10.1182/blood.2023022859 Cahill JA, Smith LA, Gottipati S, Torabi TS, Graim K. Bringing the Genomic Revolution to Comparative Oncology: Human and Dog Cancers. Annu Rev Biomed Data Sci. 2024 Apr 22. doi: 10.1146/annurev-biodatasci-102423-111936 See all Mechanisms of Oncogenesis publications.
|
|
